ATRA - Atara Biotherapeutics, Inc.

QQQ $ 481.13 $ 0.01 (0 %)

DIA $ 408.06 $ -1.17 (-0.29 %)

SPY $ 559.76 $ -0.17 (-0.03 %)

TLT $ 98.86 $ 0.18 (0.18 %)

GLD $ 231.71 $ 0.05 (0.02 %)

Previous Close

$ 7.18

Open

$ 7.04

Bid

$ 7.06 x 100

Ask

-- x --

Day's Range

$ 7.04 - $ 7.07

52 Week Range

$ 4.97 - $ 49.00

Volume

40,196

Average Volume

Market Cap

44.11M

Beta (5Y Monthly)

$ 1.49

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-12-2024	06-30-2024	10-Q
2	05-09-2024	03-31-2024	10-Q
3	03-28-2024	12-31-2023	10-K
4	11-01-2023	09-30-2023	10-Q
5	08-08-2023	06-30-2023	10-Q
6	05-08-2023	03-31-2023	10-Q
7	02-08-2023	12-31-2022	10-K
8	11-08-2022	09-30-2022	10-Q
9	08-08-2022	06-30-2022	10-Q
10	05-05-2022	03-31-2022	10-Q
11	02-28-2022	12-31-2021	10-K
12	11-04-2021	09-30-2021	10-Q
13	08-09-2021	06-30-2021	10-Q
14	05-04-2021	03-31-2021	10-Q
15	03-01-2021	12-31-2020	10-K
16	11-09-2020	09-30-2020	10-Q
17	08-05-2020	06-30-2020	10-Q
18	05-06-2020	03-31-2020	10-Q
19	02-27-2020	12-31-2019	10-K
20	11-07-2019	09-30-2019	10-Q
21	08-08-2019	06-30-2019	10-Q
22	05-09-2019	03-31-2019	10-Q
23	02-26-2019	12-31-2018	10-K
24	11-06-2018	09-30-2018	10-Q
25	08-01-2018	06-30-2018	10-Q
26	05-08-2018	03-31-2018	10-Q
27	02-27-2018	12-31-2017	10-K
28	11-09-2017	09-30-2017	10-Q
29	08-07-2017	06-30-2017	10-Q
30	05-04-2017	03-31-2017	10-Q
31	03-09-2017	12-31-2016	10-K
32	11-04-2016	09-30-2016	10-Q
33	08-08-2016	06-30-2016	10-Q
34	05-06-2016	03-31-2016	10-Q
35	03-04-2016	12-31-2015	10-K
36	11-06-2015	09-30-2015	10-Q
37	08-07-2015	06-30-2015	10-Q
38	05-11-2015	03-31-2015	10-Q
39	02-26-2015	12-31-2014	10-K
40	11-12-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Reiterates Neutral on ...
08/21/2024 12:19:22

HC Wainwright & Co. analyst Robert Burns reiterates Atara Biotherapeutics (NASDAQ:ATRA) with a Neutral.

Mizuho Upgrades Atara Biotherapeutics to O...
08/16/2024 17:42:34

Mizuho analyst Salim Syed upgrades Atara Biotherapeutics (NASDAQ:ATRA) from Neutral to Outperform and lowers the price targe...

Canaccord Genuity Maintains Buy on Atara B...
08/13/2024 16:19:54

Canaccord Genuity analyst John Newman maintains Atara Biotherapeutics (NASDAQ:ATRA) with a Buy and maintains $13 price target.

Atara Biotherapeutics Expects Cash Runway ...
08/12/2024 21:17:23

It plans to initiate ATA3219 Systemic Lupus Erythematosus trial in the fourth quarter, including the cohort without lymphodeple...

Atara Biotherapeutics Q2 2024 GAAP EPS $(3...
08/12/2024 21:15:26

Atara Biotherapeutics (NASDAQ:ATRA) reported quarterly losses of $(3.10) per share which missed the analyst consensus estimate ...

Goldman Sachs Maintains Sell on Atara Biot...
07/17/2024 15:58:12

Goldman Sachs analyst Tommie Reerink maintains Atara Biotherapeutics (NASDAQ:ATRA) with a Sell and lowers the price target f...

Atara Biotherapeutics Receives FDA Accepta...
07/17/2024 13:05:52

Prescription Drug User Fee Act (PDUFA) Target Action Date of January 15, 2025If Approved, Tab-cel Would Be First Approved Thera...

Trading Halt: Halted at 7:50:00 p.m. ET - ...
06/18/2024 23:50:04

why-ovid-therapeutics-shares-are-trading-lower-by-19-here-are-other-stocks-moving-in-mondays-mid-day-session

Why Ovid Therapeutics Shares Are Trading L...
06/17/2024 17:21:47

12-health-care-stocks-moving-in-mondays-intraday-session

12 Health Care Stocks Moving In Monday's I...
06/17/2024 16:31:43

Atara Biotherapeutics To Conduct 1-for-25 ...
06/17/2024 12:06:18

12-health-care-stocks-moving-in-fridays-after-market-session

12 Health Care Stocks Moving In Friday's A...
05/31/2024 20:32:51

Atara Biotherapeutics To Present Preclinic...
05/29/2024 20:02:12

ATA3219 Demonstrates Complete CD19-Specific B-Cell Depletion Against Systemic Lupus Erythematosus and Multiple Sclerosis Patien...

HC Wainwright & Co. Reiterates Neutral on ...
05/22/2024 11:07:58

HC Wainwright & Co. analyst Robert Burns reiterates Atara Biotherapeutics (NASDAQ:ATRA) with a Neutral.

Atara Biotherapeutics Submits Tabelecleuce...
05/20/2024 13:27:03

First Allogeneic T-Cell Therapy BLA Submission to U.S. Food and Drug AdministrationIf Approved, Tab-cel Would be First Approved...

Atara Biotherapeutics Q1 2024 GAAP EPS $(0...
05/09/2024 20:46:53

Atara Biotherapeutics (NASDAQ:ATRA) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of...

12-health-care-stocks-moving-in-tuesdays-after-market-session

12 Health Care Stocks Moving In Tuesday's ...
05/07/2024 20:31:08

12-health-care-stocks-moving-in-mondays-after-market-session

12 Health Care Stocks Moving In Monday's A...
04/08/2024 20:31:20

Stifel Maintains Hold on Atara Biotherapeu...
04/01/2024 14:55:57

Stifel analyst Benjamin Burnett maintains Atara Biotherapeutics (NASDAQ:ATRA) with a Hold and lowers the price target from $...

Atara Biotherapeutics Q4 EPS $(0.56) Misse...
03/28/2024 15:12:41

Atara Biotherapeutics (NASDAQ:ATRA) reported quarterly losses of $(0.56) per share which missed the analyst consensus estimate ...